{"nct_id":"NCT05152147","title":"A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-12-02","start_date_type":"ACTUAL","primary_completion_date":"2025-10-15","primary_completion_date_type":"ESTIMATED","completion_date":"2026-05-15","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JAZZ"]}